Metraipolis › archive › dc_ae115f2349c2

Current Status of Research on Losartan in Tumour Therapy — Europe PMC PMID:41486497

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41486497
DOI
10.1111/jcmm.70985
License (as archived)
solo-consultazione
Archived
2026-11-07T05:45:25.298Z
SHA-256 of the archived text
c50c1686d5d0afb16e32e3c2fb6637ce8b3ae004e8d0ccbb0847c3e2b38f419d
Stable URL of this page
https://metraipolis.com/documento/dc_ae115f2349c2

How to cite

Current Status of Research on Losartan in Tumour Therapy — Europe PMC PMID:41486497 — Europe PMC (en), https://europepmc.org/article/MED/41486497 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae115f2349c2 (Metraipolis archive dc_ae115f2349c2, sha256 c50c1686d5d0afb16e32e3c2fb6637ce8b3ae004e8d0ccbb0847c3e2b38f419d)
BibTeX
@misc{dcae115f2349c2,
  title = {Current Status of Research on Losartan in Tumour Therapy — Europe PMC PMID:41486497},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41486497},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae115f2349c2; sha256 c50c1686d5d0afb16e32e3c2fb6637ce8b3ae004e8d0ccbb0847c3e2b38f419d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41486497. Agents can read the archived copy with the MCP tool read_document.